ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

EUDA vs LFMD // EV/EBITDA & P/E VALUATION

EUDA Health Holdings Limited (NASDAQ) VS. LifeMD Inc. (NASDAQ) • 15-METRIC TALLY: EUDA 2 — LFMD 8
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (EUDA VS. LFMD) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC EUDA LFMD SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 43.90% 85.70% -41.80 LFMD /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -26.20% -8.80 LFMD /roic <GO>
EV/EBITDA & P/E Valuation ACTIVE — — — TIE /valuation <GO>
Free Cash Flow Yield -5.39% 5.73% -11.12 LFMD /fcf-yield <GO>
Operating Margin -36.30% -4.00% -32.30 LFMD /operating-margins <GO>
Net Profit Margin -40.70% -5.80% -34.90 LFMD /net-margins <GO>
Revenue Growth (YoY) 70.00% 25.30% +44.70 EUDA /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 2.78% -2.78 LFMD /dividend-safety <GO>
Altman Z-Score & Debt/Equity — 0.20 — TIE /balance-sheet <GO>
Piotroski F-Score Quality 4/9 6/9 -2.00 LFMD /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 59.7 38.8 +20.94 EUDA /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $46.4M $111.8M -$65.4M LFMD /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR EUDA REV LFMD REV EUDA GROSS % LFMD GROSS % EUDA FCF LFMD FCF
FY 2025 $6.8M $194.1M 43.9% 85.7% -$2.5M $6.4M
FY 2024 $4.0M $154.8M 19.0% 86.2% -$2.1M $16.0M
FY 2023 $3.7M $152.5M — — -$2.9M $8.8M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
EUDA // BETA —
LFMD // BETA —